Michael Bishop

Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation

James N. Kochenderfer, Mark E. Dudley, Robert O. Carpenter et al. · Blood · 2013 · 590 citations · Full text

Medicine, Hematology, Immunology +13

Proceedings from the National Cancer Institute’s Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part III. Prevention and Treatment of Relapse after Allogeneic Transplantation

Marcos de Lima, David L. Porter, Minoo Battiwalla et al. · Biology of Blood and Marrow Transplantation · 2013 · 141 citations · Full text

Medicine, Hematology, Immunology +17

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation

David Porter, Edwin P. Alyea, Joseph H. Antin et al. · Biology of Blood and Marrow Transplantation · 2010 · 138 citations · Full text

Medicine, Hematology, Immunology +16

Association of Serum Interleukin-7 Levels With the Development of Acute Graft-Versus-Host Disease

Robert M. Dean, Terry J. Fry, Crystal L. Mackall et al. · Journal of Clinical Oncology · 2008 · 92 citations

Life Sciences, Hematology, Immunology +10

Up-regulation of NK Cell Activating Receptors Following Allogeneic Hematopoietic Stem Cell Transplantation under a Lymphodepleting Reduced Intensity Regimen is Associated with Elevated IL-15 Levels

Michael Boyiadzis, Sarfraz Memon, Jesse Carson et al. · Biology of Blood and Marrow Transplantation · 2008 · 70 citations · Full text

Life Sciences, Immunology, Oncology +16